Tag : Ono Pharmaceutical Co.

Regulatory Compliance & Risk Management

Ono Pharma Seeks Approval for Ripretinib in GIST Patients Japan

Business Wire
by Business Wire016
Ono Pharmaceutical Co., Ltd. that Ono submitted an application for the manufacturing and marketing approval of ripretinib (DCC-2618), developed by Deciphera Pharmaceuticals, Inc. (“Deciphera”), for...
Clinical Research, Pharma & Healthcare Financing

Ono Licenses Sapablursen from Ionis for Polycythemia Vera

Business Wire
by Business Wire0238
Ono Pharmaceutical Co., Ltd. announced that it has entered into a license agreement with Ionis Pharmaceuticals, Inc. for sapablursen, an investigational RNA-targeted medicine for the...